Altamont Looks to Medical Devices

Altamont Capital Partners has added Sharon Luboff to its team as an operating partner. Ms. Luboff and John Barr, also an operating partner at Altamont, have been tasked with acquiring and building a new medical device platform.

Ms. Luboff has 37 years of experience in the medical device industry. Most recently she was as a group vice president at C.R. Bard, a New Jersey-based developer and manufacturer of vascular, urology, oncology, and surgical medical devices, that was acquired by Becton Dickinson in 2017.  At Bard, she had corporate-wide responsibility for business development and strategy and she led more than 20 transactions for the company. Prior to joining Bard, she spent over 20 years at Baxter Healthcare in a variety of senior management positions. Ms. Luboff has her MBA and undergraduate degrees from Northwestern University.

“We are excited to capitalize on the compelling industry trends in the medical device segment, and this partnership positions us well to evaluate and pursue a wide range of assets,” said Casey Lynch, a managing director at Altamont. “Sharon’s demonstrated ability to lead and grow strong device businesses is an incredible asset to the firm.”

“I am excited to formalize my relationship with the Altamont team,” said Ms. Luboff. “Altamont’s business building orientation and successful track record around both corporate carveouts and founder/family transitions makes the firm the perfect partner. I am confident there are many opportunities to invest capital in the medical device sector that will benefit from our combined skills and experience.”

“We have developed a strong relationship with Sharon over time and have been consistently impressed with her industry expertise, strategic insights and track record of both operational and M&A success,” said Melissa Francis, a principal at Altamont. “We are thrilled to welcome her to the team. The partnership between Sharon and John, and their combined depth and breadth of experience, will enable us to pursue a wide range of opportunities in the medical device sector.”

Like Ms. Luboff, Mr. Barr has spent his entire career in the medical device sector. He joined Altamont in 2018 and from 2014 to 2017 he was the CEO of Surgical Specialties, a Boston-based medical device company specializing in sutures and surgical instruments. Earlier in his career, he served as president of Bausch & Lomb’s ophthalmic surgical products group. Bausch & Lomb was acquired by Valeant Pharmaceuticals in 2013.

Altamont invests equity of $15 million to $100 million in companies that have up to $50 million of EBITDA. Sectors of interest include business services; consumer; financial services; healthcare; industrial; retail, restaurants, and franchising; and technology.  The firm was formed in 2010 by Jesse Rogers, Randall Eason and Keoni Schwartz who previously worked together at Golden Gate Capital and Bain & Company. The firm has $2.5 billion of capital under management and is based in Palo Alto, CA (www.altamontcapital.com).

© 2019 Private Equity Professional | July 25, 2019

Print Friendly, PDF & Email

Related Articles

Party On? The protracted strong market for business sellers continues to be a party that shows no sign of winding down, according to GF Data’s report on private...
Great Point Hits Fund III Hard Cap Great Point Partners has held a final closing of Great Point Partners III LP (GPP III) at its hard cap of $306 million. The new fund was oversubscribe...
Bonaccord and Wafra Take Minority Piece of AEI Bonaccord Capital Partners and Wafra, Inc. have closed a minority investment in private equity firm AE Industrial Partners (AEI). Boca Raton-based ...
Silver Oak Hits Fund IV Hard Cap Silver Oak Services Partners has closed its latest fund, Silver Oak Services Partners Fund IV LP, at its hard cap of $500 million. With the closing...
Billions in Opportunity in Automotive Supply Deloitte has published its fourth "Global Automotive Supplier Study" which analyzes shareholder value performance for more than 200 automotive supplie...
Regal Closes Fund II at Hard Cap Regal Healthcare Capital Partners (RHCP) has held a first and final closing of its second private equity fund, RHCP II LP (Fund II) at its hard cap of...